Off-Label Use of Ozempic-Style Drugs Is Surging

A large new study suggests weight-loss drugs have quietly moved from medical tool to what one researcher calls a "big Ozempic experiment." Reviewing records for more than 92 million US adults, researchers found over 1.1 million people on GLP-1 medications with no documented condition—such as obesity or diabetes—...